Trials / Completed
CompletedNCT04338438
Efficacy and Safety of Apatinib Combined With S-1 for Patients With Advance Gastric Cancer
Apatinib Plus S-1 for Advanced Gastric Cancer Refractory to Oxaliplatin Plus Capecitabine Combination Therapy: A Single-arm, Phase-2, Home-based Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- Beijing Friendship Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a single-arm, interventional study aimed to observe the efficacy and safety of Apatinib combined with S-1 for patients with advanced gastric cancer refractory to oxaliplatin plus capecitabine combination therapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Apatinib Mesylate tablets combined with S-1 capsules | Apatinib Mesylate tablets combined with S-1 capsules, p.o. |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2019-04-30
- Completion
- 2020-01-31
- First posted
- 2020-04-08
- Last updated
- 2020-11-10
Source: ClinicalTrials.gov record NCT04338438. Inclusion in this directory is not an endorsement.